PARACETAMOL SANDOZ 10 mg/ml infuusioneste, liuos Finland - Finnish - Fimea (Suomen lääkevirasto)

paracetamol sandoz 10 mg/ml infuusioneste, liuos

sandoz a/s sandoz a/s - paracetamolum - infuusioneste, liuos - 10 mg/ml - parasetamoli

Pamolhot-C 750 mg / 300 mg porejauhe Finland - Finnish - Fimea (Suomen lääkevirasto)

pamolhot-c 750 mg / 300 mg porejauhe

orifarm healthcare a/s - ascorbic acid, paracetamol - porejauhe - 750 mg / 300 mg - parasetamoli

PARA-CAPS 500 mg kapseli, pehmeä Finland - Finnish - Fimea (Suomen lääkevirasto)

para-caps 500 mg kapseli, pehmeä

orion corporation - paracetamolum - kapseli, pehmeä - 500 mg - parasetamoli

Parasetamoli Ya 500 mg tabletti Finland - Finnish - Fimea (Suomen lääkevirasto)

parasetamoli ya 500 mg tabletti

galena pharma oy - paracetamol - tabletti - 500 mg - parasetamoli

Carmustine medac (previously Carmustine Obvius) European Union - Finnish - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - antineoplastiset aineet - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

Azacitidine Celgene European Union - Finnish - EMA (European Medicines Agency)

azacitidine celgene

celgene europe bv - atsakitidiini - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastiset aineet - azacitidine celgene is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification,aml with >30% marrow blasts according to the who classification.

Mucoratio 200 mg poretabletti Finland - Finnish - Fimea (Suomen lääkevirasto)

mucoratio 200 mg poretabletti

teva b.v. - acetylcysteine - poretabletti - 200 mg - asetyylikysteiini

Tramadol/Paracetamol Krka 37.5 mg / 325 mg tabletti, kalvopäällysteinen Finland - Finnish - Fimea (Suomen lääkevirasto)

tramadol/paracetamol krka 37.5 mg / 325 mg tabletti, kalvopäällysteinen

krka, d.d., novo mesto - paracetamol, tramadol hydrochloride - tabletti, kalvopäällysteinen - 37.5 mg / 325 mg - tramadoli ja parasetamoli

Tramadol/Paracetamol Krka 75 mg / 650 mg tabletti, kalvopäällysteinen Finland - Finnish - Fimea (Suomen lääkevirasto)

tramadol/paracetamol krka 75 mg / 650 mg tabletti, kalvopäällysteinen

krka, d.d., novo mesto - paracetamol, tramadol hydrochloride - tabletti, kalvopäällysteinen - 75 mg / 650 mg - tramadoli ja parasetamoli

Carmustine Macure 100 mg kuiva-aine ja liuotin välikonsentraatiksi infuusionestettä varten, liuos Finland - Finnish - Fimea (Suomen lääkevirasto)

carmustine macure 100 mg kuiva-aine ja liuotin välikonsentraatiksi infuusionestettä varten, liuos

macure pharma aps - carmustine - kuiva-aine ja liuotin välikonsentraatiksi infuusionestettä varten, liuos - 100 mg - karmustiini